ArticleImmunometabolism2022
A Compass to Guide Insights into T
Adrianna N Wilson, Sarah A Mosure, Laura A Solt
Open access · diamondAbstract readComment
In one paragraphArticle in Immunometabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 58% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 2 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
3 authors at 1 institution in 1 country.
Adrianna N WilsonDepartment of Immunology and Microbiology, The Scripps Research Institute, Jupiter, FL 33458, USA.
Sarah A MosureDepartment of Immunology and Microbiology, The Scripps Research Institute, Jupiter, FL 33458, USA.
Laura A SoltDepartment of Immunology and Microbiology, The Scripps Research Institute, Jupiter, FL 33458, USA.
Scripps Research Institute · US
Funding
Identification of REV-ERB inverse agonists for cancer immunotherapyR01CA241816 · NCI · UNIVERSITY OF FLORIDA · PI SOLT, LAURA A · 2019 to 2022
$2.5MRegulation of TH17 Cell Development and Function by the REV-ERBsR01AI116885 · NIAID · SCRIPPS FLORIDA · PI SOLT, LAURA A · 2016 to 2020
$2.1MIdentification of Chemical Probes for the Orphan Nuclear Receptor NR2F6R01CA225890 · NCI · UNIVERSITY OF FLORIDA · PI SCAMPAVIA, LOUIS DANIEL, SOLT, LAURA A · 2018 to 2020
$1.6MIntegrated Acoustic Transfer System for HTS Library ManagementS10OD025279 · OD · SCRIPPS FLORIDA · PI SCAMPAVIA, LOUIS DANIEL · 2018 to 2018
$624kTandem Multi-modal Plate Readers for a High Throughput Screening platformS10OD030330 · OD · UNIVERSITY OF FLORIDA · PI SCAMPAVIA, LOUIS DANIEL · 2021 to 2021
$600kHTS Drug Discovery DispensersS10OD026857 · OD · SCRIPPS FLORIDA · PI SCAMPAVIA, LOUIS DANIEL · 2019 to 2019
$452kElucidating the molecular mechanisms underlying ligand-dependent REV-ERB activity in Th17 cellsF31DK127643 · NIDDK · UNIVERSITY OF FLORIDA · PI MOSURE, SARAH · 2021 to 2022
$67kNCI NIH HHS R01 CA225890NCI NIH HHS R01 CA241816NIAID NIH HHS R01 AI116885NIDDK NIH HHS F31 DK127643NIH HHS S10 OD025279NIH HHS S10 OD026857NIH HHS S10 OD030330
6 · The paper itselfAbstract
T cells rapidly convert their cellular metabolic requirements upon activation, switching to a highly glycolytic program to satisfy their increasingly complex energy needs. Fundamental metabolic differences have been established for the development of Foxp3
Indexed as
arginineFoxp3glycolysisinflammationmetabolismpolyamineTH17 cellT regulatory
Identifiers
PMID34900348
PMCPMC8654074
OpenAlexW3217300602
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390